Evidence map›Paper›PMID 34606337›Full record

ArticleAntimicrobial agents and chemotherapy2021

Efficacy of Nanoencapsulated Daptomycin in an Experimental Methicillin-Resistant Staphylococcus aureus Bone and Joint Infection Model.

Cedric Jacqueline, Jocelyne Caillon, Olivier Meyer, Eric Dailly, Carl Simonsson, Vincent Lenaerts, Karim Asehnoune, Amokrane Reghal, Gilles Potel

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Cedric JacquelineUniversité de Nantes, EA3826, IRS2 Nantes Biotech, Nantes, France.ORCID 0000-0001-9606-5930
Jocelyne CaillonUniversité de Nantes, EA3826, IRS2 Nantes Biotech, Nantes, France.
Olivier MeyerCarlina Technologies, Angers, France.
Eric DaillyCHU Nantes, Service de Pharmacologie, Nantes, France.
Carl SimonssonCarlina Technologies, Angers, France.
Vincent LenaertsTrochylus Pharma Inc., Mississauga, Ontario, Canada.
Karim AsehnouneUniversité de Nantes, EA3826, IRS2 Nantes Biotech, Nantes, France.
Amokrane ReghalAtlangram, IRS2 Nantes Biotech, Nantes, France.
Gilles PotelUniversité de Nantes, EA3826, IRS2 Nantes Biotech, Nantes, France.
Nantes Université · FRCentre Hospitalier Universitaire de Nantes · FR

Funding

Atlangram Biotech
6 · The paper itself

Abstract

Staphylococcus aureus bone infections remain a therapeutic challenge, leading to long and expensive hospitalizations. Systemic antibiotic treatments are inconsistently effective, due to insufficient penetration into the infectious site. In an osteomyelitis model, the single local administration of nanoparticle-encapsulated daptomycin allows sterilization of the infectious sites after 4 and 14 days of treatment, while daily systemic daptomycin treatment for 4 days was not effective. These results demonstrate the great potential of this local antibiotic treatment.

Indexed as

Arthritis, InfectiousDaptomycinMethicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsAnti-Bacterial AgentsHumansAnti-Bacterial AgentsDaptomycindaptomycinlipopeptideslocal deliveryMRSAnanoparticlesosteomyelitis

Identifiers

PMID34606337
PMCPMC8597761
OpenAlexW3203554186

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.